New Zealand markets closed
  • NZX 50

    12,166.73
    +14.57 (+0.12%)
     
  • NZD/USD

    0.6470
    -0.0004 (-0.06%)
     
  • NZD/EUR

    0.5936
    +0.0011 (+0.18%)
     
  • ALL ORDS

    7,764.60
    +36.10 (+0.47%)
     
  • ASX 200

    7,551.10
    +39.50 (+0.53%)
     
  • OIL

    75.83
    -0.05 (-0.07%)
     
  • GOLD

    1,930.00
    -0.80 (-0.04%)
     
  • NASDAQ

    12,803.14
    +440.04 (+3.56%)
     
  • FTSE

    7,820.16
    +59.05 (+0.76%)
     
  • Dow Jones

    34,053.94
    -39.02 (-0.11%)
     
  • DAX

    15,509.19
    +328.45 (+2.16%)
     
  • Hang Seng

    21,547.82
    -410.54 (-1.87%)
     
  • NIKKEI 225

    27,511.51
    +109.46 (+0.40%)
     
  • NZD/JPY

    83.1170
    -0.0960 (-0.12%)
     

Anti-Retroviral Drugs Market is expected to generate a revenue of USD 45.50 Billion by 2030, Globally, at 6.70% CAGR: Verified Market Research®

Verified Market Research
Verified Market Research

The market report is a good combination of qualitative and quantitative data that highlights significant market changes, obstacles that business and the competition must overcome, as well as new possibilities and trends in the global Anti-Retroviral Drugs Market.

Jersey City, New Jersey, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Anti-Retroviral Drugs Market” By Type (Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors), By Application (HIV/AIDS, Herpes, Influenza), and By Geography.

As per the deep research carried out by Verified Market Research, the global Anti-Retroviral Drugs Market size was valued at USD 30.45 Billion in 2021 and is projected to reach USD 45.50 Billion by 2030, growing at a CAGR of 6.70% from 2022 to 2030.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=27063

Browse in-depth TOC onAnti-Retroviral Drugs Market

202 - Pages

126 – Tables

37 – Figures

Global Anti-Retroviral Drugs Market Overview

A group of viruses from the family Retroviridae collectively known as a retrovirus typically carry their genetic material as ribonucleic acid RNA. Antiretroviral medications prevent the HIV virus from multiplying instead of destroying it. The most effective kind of medical treatment for HIV is antiretroviral medication.

To obtain a competitive edge and enter into various regional markets, numerous companies are concentrating on developing a ground-breaking HIV treatment solution. Additionally, financing for businesses engaged in antiretroviral medicine R&D has increased. Drugs for the Human Immunodeficiency Virus (HIV) that treat HIV/AIDS are available on the market. Hospital pharmacies, online pharmacies, retail pharmacies, and others administer the medications via oral and parenteral routes.

The market for anti-retroviral drugs is expanding as a result of rising public knowledge of HIV/AIDS diagnosis and treatment. It is the most serious illness with a high prevalence in nearly every region of the world, which has led to an unparalleled level of awareness of the illness. By enhancing the ability to fight the virus and preventing the spread of HIV to others, it is used to treat lower viral loads, suppress the growth of the virus, and slow down or stop HIV symptoms.

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The “Global Anti-Retroviral Drugs Market” is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.

Key Players

The “Global Anti-Retroviral Drugs Market” study report will provide a valuable insight with an emphasis on the global market.  The major players in the market are Roche, Gilead, Bristol-Myers Squibb, Abbott, AstraZeneca, Merck, Johnson and Johnson, Boehringer Ingelheim, and Novartis AG., AbbVie Inc., F. Hoffmann-La Roche Ltd, Gilead Sciences, Merck & Co. Inc., Mylan N.V., ViiV Healthcare., 9.10 Janssen Pharmaceuticals, Inc (Johnson & Johnson, Belgium) and GloaxoSmithKline plc (UK).

Based on the research, Verified Market Research has segmented the global Anti-Retroviral Drugs Market into Type, Application and Geography.

  • Anti-Retroviral Drugs Market, by Type

    • Protease Inhibitors

    • Non-Nucleoside Reverse Transcriptase Inhibitors

    • Integrase Inhibitors

    • Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

  • Anti-Retroviral Drugs Market, by Application

    • Hepatitis

    • HIV/AIDS

    • Herpes

    • Influenza

    • Others

  • Anti-Retroviral Drugs Market, by Geography

    • North America

      • U.S

      • Canada

      • Mexico

    • Europe

      • Germany

      • France

      • U.K

      • Rest of Europe

    • Asia Pacific

      • China

      • Japan

      • India

      • Rest of Asia Pacific

    • ROW

      • Middle East & Africa

      • Latin America

Browse Related Reports:

Implantable Drug Delivery Market By Technology (Biodegradable Implantable Drug Delivery Device Technology, Non-Biodegradable Implantable Drug Delivery Device Technology), By Product (Implantable Bio-Absorbable Stents, Implantable Brachytherapy Seeds), By Application (Cardiovascular, Ophthalmology, Oncology), By Geography, And Forecast

Anticoagulants Market By Drug Class (NOACs, Heparin & LMWH), By Route (Oral Anticoagulant, Injectable Anticoagulant), By Application (Atrial Fibrillation & Heart Attack, Stroke), By Geography, And Forecast

Active Pharmaceutical Ingredients (API) Market By Molecule (Small Molecule, Large Molecule), By Application (Pain Management, Respiratory Diseases), By Type (Innovative APIs, Generic APIs), By Type Of Manufacturer (Captive Manufacturers, Merchant Manufacturers), By Type Of Drug (Prescription Drugs, Over The Counter Drugs), By Geography, And Forecast

Benign Prostatic Hyperplasia Treatment Market By Drug Type (Drug treatment, Surgical treatment), By End-User (Hospitals and Clinics, Home and Healthcare), By Geography, And Forecast

Top 5 Acute Ischemic Stroke Drug Manufacturers offering breakthrough solutions

Visualize Anti-Retroviral Drugs Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

CONTACT: Mr. Edwyne Fernandes Verified Market Research® US: +1 (650)-781-4080 UK: +44 (753)-715-0008 APAC: +61 (488)-85-9400 US Toll Free: +1 (800)-782-1768 Email: sales@verifiedmarketresearch.com Web: https://www.verifiedmarketresearch.com/ BI Enabled Platform: https://www.verifiedmarketresearch.com/vmintelligence/ Follow Us: LinkedIn | Twitter